Role of targeted therapy in metastatic colorectal cancer.

World J Gastrointest Oncol · 2016 · PMC5027019 · PMID 27672422

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

Although anti-EGFR therapy in the first-line setting has a favorable trend compared with anti-VEGF therapy, the treatment strategy in RAS wild type mCRC has been controversial.

also in 1,053 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.